Dr. Michael Gulliver Erkkinen, MD

Dr. Erkkinen practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Erkkinen's NPI, 1003179276, was assigned on June 21, 2012. Dr. Erkkinen graduated from Geisel School Of Medicine At Dartmouth in 2012. Dr. Erkkinen holds Massachusetts license 271521.

Dr. Erkkinen's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Erkkinen's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Erkkinen is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Erkkinen to 2 more hospitals, 6 medical groups, 3 group practices and clinics and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Erkkinen practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Erkkinen's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Erkkinen is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Erkkinen's licenses on file in 2 states: Massachusetts and California.

Dmand AI lists alzheimer's disease, fibromyalgia and chronic pain, head injury, hereditary polyneuropathy, migraine and chronic headache, neck pain and spine problems, neuropathy and non-alzheimer's dementia (chronic) among the conditions Dr. Erkkinen treats.

CMS data shows 795 Medicare services from Dr. Erkkinen across 10 procedure codes in 2024, for 406 Medicare patients. Medicare paid $62,024 for them.

CMS counts 406 Medicare patients who saw Dr. Erkkinen in 2024. The largest group is 75 to 84, with 183 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Erkkinen's median patient age at 76, with 49% women.

In 2024, Dr. Erkkinen wrote 264 Medicare Part D claims for 66 patients. 100% of them were for generic drugs. CMS names the drug for 229 of them, across 6 drugs with 11 or more claims each, at $5,497 in total drug cost. In 2023, CMS named 158 claims across 3 drugs.

Dr. Erkkinen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Erkkinen as offering telehealth.

Dmand AI links 22 papers to Dr. Erkkinen, published from 2012 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Magnetic Resonance Imaging, Brain and Brain Mapping. Dr. Erkkinen has published most often in Neurology. Dr. Erkkinen's most frequent co-authors are Arnab Chakravarti, MD, Allen Richard Braun, MD and Kirk R. Daffner, MD.

CMS Open Payments shows 6 general payments to Dr. Erkkinen from 2 drug and device companies from 2017 to 2022. Consulting fees make up the largest share, 96% of the total. Biogen, Inc. paid the most, $6,963. It also lists 2 research payments totaling $26,396 from 2021 to 2024.

Dr. Erkkinen graduated from Geisel School Of Medicine At Dartmouth in 2012. Dr. Erkkinen is a member of AAN.

Dr. Erkkinen is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.